Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 429
Filtrar
2.
Comput Biol Chem ; 96: 107602, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-34823125

RESUMEN

Herein it is proposed that sufficient exposure to sunlight (UVB) modulates host gene expression, offering protection against severe consequences of COVID-19. This could be in addition to sunlight (UVB)-mediated protection by directly inactivating the virus and limiting the viral load. It is suggested that inhibition of CCR2, DPP9, HSPA1L, IFNAR2, OAS1, and TYK2 may, in part, explain UVB-mediated protection against severe consequences of COVID-19.


Asunto(s)
COVID-19/prevención & control , SARS-CoV-2 , Luz Solar , COVID-19/genética , COVID-19/terapia , Biología Computacional , Expresión Génica/efectos de la radiación , Perfilación de la Expresión Génica , Helioterapia , Humanos , Modelos Biológicos , Índice de Severidad de la Enfermedad , Rayos Ultravioleta
3.
Cochrane Database Syst Rev ; 7: CD013277, 2021 07 06.
Artículo en Inglés | MEDLINE | ID: mdl-34228352

RESUMEN

BACKGROUND: Acute bilirubin encephalopathy (ABE) and the other serious complications of severe hyperbilirubinemia in the neonate occur far more frequently in low- and middle-income countries (LMIC). This is due to several factors that place babies in LMIC at greater risk for hyperbilirubinemia, including increased prevalence of hematologic disorders leading to hemolysis, increased sepsis, less prenatal or postnatal care, and a lack of resources to treat jaundiced babies. Hospitals and clinics face frequent shortages of functioning phototherapy machines and inconsistent access to electricity to run the machines. Sunlight has the potential to treat hyperbilirubinemia: it contains the wavelengths of light that are produced by phototherapy machines. However, it contains harmful ultraviolet light and infrared radiation, and prolonged exposure has the potential to lead to sunburn, skin damage, and hyperthermia or hypothermia. OBJECTIVES: To evaluate the efficacy of sunlight administered alone or with filtering or amplifying devices for the prevention and treatment of clinical jaundice or laboratory-diagnosed hyperbilirubinemia in term and late preterm neonates. SEARCH METHODS: We used the standard search strategy of Cochrane Neonatal to search CENTRAL (2019, Issue 5), MEDLINE, Embase, and CINAHL on 2 May 2019. We also searched clinical trials databases, conference proceedings, and the reference lists of retrieved articles for randomized controlled trials (RCTs), quasi-RCTs, and cluster RCTs. We updated the searches on 1 June 2020. SELECTION CRITERIA: We included RCTs, quasi-RCTs, and cluster RCTs. We excluded crossover RCTs. Included studies must have evaluated sunlight (with or without filters or amplification) for the prevention and treatment of hyperbilirubinemia or jaundice in term or late preterm neonates. Neonates must have been enrolled in the study by one-week postnatal age. DATA COLLECTION AND ANALYSIS: We used standard methodologic procedures expected by Cochrane. We used the GRADE approach to assess the certainty of evidence. Our primary outcomes were: use of conventional phototherapy, treatment failure requiring exchange transfusion, ABE, chronic bilirubin encephalopathy, and death. MAIN RESULTS: We included three RCTs (1103 infants). All three studies had small sample sizes, were unblinded, and were at high risk of bias. We planned to undertake four comparisons, but only found studies reporting on two. Sunlight with or without filters or amplification compared to no treatment for the prevention and treatment of hyperbilirubinemia in term and late preterm neonates One study of twice-daily sunlight exposure (30 to 60 minutes) compared to no treatment reported the incidence of jaundice may be reduced (risk ratio [RR] 0.61, 95% confidence interval [CI] 0.45 to 0.82; risk difference [RD] -0.14, 95% CI -0.22 to -0.06; number needed to treat for an additional beneficial outcome [NNTB] 7, 95% CI 5 to 17; 1 study, 482 infants; very low-certainty evidence) and the number of days that an infant was jaundiced may be reduced (mean difference [MD] -2.20 days, 95% CI -2.60 to -1.80; 1 study, 482 infants; very low-certainty evidence). There were no data on safety or potential harmful effects of the intervention. The study did not assess use of conventional phototherapy, treatment failure requiring exchange transfusion, ABE, and long-term consequences of hyperbilirubinemia. The study showed that sunlight therapy may reduce rehospitalization rates within seven days of discharge for treatment for hyperbilirubinemia, but the evidence was very uncertain (RR 0.55, 95% CI 0.27 to 1.11; RD -0.04, -0.08 to 0.01; 1 study, 482 infants; very low-certainty evidence). Sunlight with or without filters or amplification compared to other sources of phototherapy for the treatment of hyperbilirubinemia in infants with confirmed hyperbilirubinemia Two studies (621 infants) compared the effect of filtered-sunlight exposure to other sources of phototherapy in infants with confirmed hyperbilirubinemia. Filtered-sunlight phototherapy (FSPT) and conventional or intensive electric phototherapy led to a similar number of days of effective treatment (broadly defined as a minimal increase of total serum bilirubin in infants less than 72 hours old and a decrease in total serum bilirubin in infants more than 72 hours old on any day that at least four to five hours of sunlight therapy was available). There may be little or no difference in treatment failure requiring exchange transfusion (typical RR 1.00, 95% CI 0.06 to 15.73; typical RD 0.00, 95% CI -0.01 to 0.01; 2 studies, 621 infants; low-certainty evidence). One study reported ABE, and no infants developed this outcome (RR not estimable; RD 0.00, 95% CI -0.02 to 0.02; 1 study, 174 infants; low-certainty evidence). One study reported death as a reason for study withdrawal; no infants were withdrawn due to death (RR not estimable; typical RD 0.00, 95% CI -0.01 to 0.01; 1 study, 447 infants; low-certainty evidence). Neither study assessed long-term outcomes. Possible harms: both studies showed a probable increased risk for hyperthermia (body temperature greater than 37.5 °C) with FSPT (typical RR 4.39, 95% CI 2.98 to 6.47; typical RD 0.30, 95% CI 0.23 to 0.36; number needed to treat for an additional harmful outcome [NNTH] 3, 95% CI 2 to 4; 2 studies, 621 infants; moderate-certainty evidence). There was probably no difference in hypothermia (body temperature less than 35.5 °C) (typical RR 1.06, 95% CI 0.55 to 2.03; typical RD 0.00, 95% CI -0.03 to 0.04; 2 studies, 621 infants; moderate-certainty evidence). AUTHORS' CONCLUSIONS: Sunlight may be an effective adjunct to conventional phototherapy in LMIC settings, may allow for rotational use of limited phototherapy machines, and may be preferable to families as it can allow for increased bonding. Filtration of sunlight to block harmful ultraviolet light and frequent temperature checks for babies under sunlight may be warranted for safety. Sunlight may be effective in preventing hyperbilirubinemia in some cases, but these studies have not demonstrated that sunlight alone is effective for the treatment of hyperbilirubinemia given its sporadic availability and the low or very low certainty of the evidence in these studies.


Asunto(s)
Helioterapia/métodos , Hiperbilirrubinemia Neonatal/terapia , Sesgo , Recambio Total de Sangre , Helioterapia/efectos adversos , Helioterapia/instrumentación , Humanos , Hiperbilirrubinemia Neonatal/epidemiología , Hiperbilirrubinemia Neonatal/prevención & control , Hipertermia/epidemiología , Hipotermia/epidemiología , Incidencia , Recién Nacido , Recien Nacido Prematuro , Ictericia Neonatal/prevención & control , Ictericia Neonatal/terapia , Readmisión del Paciente/estadística & datos numéricos , Ensayos Clínicos Controlados Aleatorios como Asunto , Insuficiencia del Tratamiento
4.
Sci Rep ; 11(1): 5031, 2021 03 03.
Artículo en Inglés | MEDLINE | ID: mdl-33658568

RESUMEN

Exposure to appropriate doses of UV radiation provides enormously health and medical treatment benefits including psoriasis. Typical hospital-based phototherapy cabinets contain a bunch of artificial lamps, either broad-band (main emission spectrum 280-360 nm, maximum 320 nm), or narrow-band UV B irradiation (main emission spectrum 310-315 nm, maximum 311 nm). For patients who cannot access phototherapy centers, sunbathing, or heliotherapy, can be a safe and effective treatment alternative. However, as sunlight contains the full range of UV radiation (290-400 nm), careful sunbathing supervised by photodermatologist based on accurate UV radiation forecast is vital to minimize potential adverse effects. Here, using 10-year UV radiation data collected at Nakhon Pathom, Thailand, we developed a deep learning model for UV radiation prediction which achieves around 10% error for 24-h forecast and 13-16% error for 7-day up to 4-week forecast. Our approach can be extended to UV data from different geographical regions as well as various biological action spectra. This will become one of the key tools for developing national heliotherapy protocol in Thailand. Our model has been made available at https://github.com/cmb-chula/SurfUVNet .


Asunto(s)
Aprendizaje Profundo , Helioterapia/métodos , Psoriasis/radioterapia , Dosis de Radiación , Terapia Ultravioleta/métodos , Benchmarking , Conjuntos de Datos como Asunto , Humanos , Radiometría , Luz Solar , Rayos Ultravioleta
5.
Artículo en Ruso | MEDLINE | ID: mdl-33307664

RESUMEN

OBJECTIVE: Scientometrical analysis of studies the use of climatotherapy methods and formulation of guidelines based on the evidence obtained during the analysis. MATERIAL AND METHODS: The article presents the data of scientometrical analysis of 40 publications on the use of climatotherapy in spa practice. RESULTS: Clinical effects and proposed mechanisms of action of the proven efficacy climatotherapy methods - aerotherapy, heliotherapy and thalassotherapy for the patients with various chronic diseases are presented. The clinical directions for the using of climatotherapy methods in climatic resorts are highlighted. CONCLUSIONS: Regular generalization and analysis of existing evidence-based studies is required, as well as the implementation of new high-quality randomized controlled clinical trials to study the effects of climate therapy on a wide range of patients with common socially significant diseases.


Asunto(s)
Climatoterapia , Enfermedad Crónica , Colonias de Salud , Helioterapia , Humanos , Modalidades de Fisioterapia
7.
J Photochem Photobiol B ; 207: 111891, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32388486

RESUMEN

The recent outbreak of COVID-19, which continues to ravage communities with high death tolls and untold psychosocial and catastrophic economic consequences, is a vivid reminder of nature's capacity to defy contemporary healthcare. The pandemic calls for rapid mobilization of every potential clinical tool, including phototherapy-one of the most effective treatments used to reduce the impact of the 1918 "Spanish influenza" pandemic. This paper cites several studies showing that phototherapy has immense potential to reduce the impact of coronavirus diseases, and offers suggested ways that the healthcare industry can integrate modern light technologies in the fight against COVID-19 and other infections. The evidence shows that violet/blue (400-470 nm) light is antimicrobial against numerous bacteria, and that it accounts for Niels Ryberg Finsen's Nobel-winning treatment of tuberculosis. Further evidence shows that blue light inactivates several viruses, including the common flu coronavirus, and that in experimental animals, red and near infrared light reduce respiratory disorders, similar to those complications associated with coronavirus infection. Moreover, in patients, red light has been shown to alleviate chronic obstructive lung disease and bronchial asthma. These findings call for urgent efforts to further explore the clinical value of light, and not wait for another pandemic to serve as a reminder. The ubiquity of inexpensive light emitting lasers and light emitting diodes (LEDs), makes it relatively easy to develop safe low-cost light-based devices with the potential to reduce infections, sanitize equipment, hospital facilities, emergency care vehicles, homes, and the general environment as pilot studies have shown.


Asunto(s)
Infecciones por Coronavirus/terapia , Fototerapia , COVID-19 , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/virología , Helioterapia , Humanos , Rayos Infrarrojos , Luz , Terapia por Luz de Baja Intensidad , Enfermedades Pulmonares/epidemiología , Enfermedades Pulmonares/terapia , Enfermedades Pulmonares/virología , Pandemias , Fototerapia/métodos , Neumonía Viral
8.
Int J Biometeorol ; 64(7): 1145-1152, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32133542

RESUMEN

This study assessed the effects of liman peloid, followed by bath and heliotherapy in psoriatic patients at Cervia, Emilia, Italy. The psoriatic patients were randomized into two groups: group 1 with 56 patients, treated with liman applications, bath, and heliotherapy, and group 2 with 35 subjects, treated with mud-bath therapy using a clay peloid mixed with tap water and heliotherapy. Data was collected for the following: psoriasis area and severity index (PASI); delta-PASI (difference between post- and pre-treatment PASI); delta-PASI3 and delta-PASI6, 3 and 6 months after the end of treatment, respectively; psoriasis recurrences; and the use of both topical and systemic drugs. Although not significant, a decrease in PASI was recorded in group 1 at the end of treatment and after 3 and 6 months. Compared with group 2, there was a significant change in delta-PASI, delta-PASI3, and psoriasis recurrences in group 1 as well as a significant reduction in the topical use of drugs, both cortisone and nonsteroid drugs. This is the first and preliminary study which documented the efficacy of a specific protocol of liman bath heliotherapy in psoriatic patients as documented by a reduction in delta-PASI and delta-PASI3, a decrease in psoriasis recurrences, and use of topical drugs.


Asunto(s)
Helioterapia , Psoriasis , Baños , Humanos , Italia , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
9.
Pediatr Dermatol ; 36(5): 690-692, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31313355

RESUMEN

Lichen nitidus is a benign inflammatory dermatosis that typically presents in a localized distribution. We present the rare case of a 6-year-old boy with a 1-year history of generalized lichen nitidus with limited access to narrowband ultraviolet B phototherapy. Over the course of a summer, he had complete and lasting resolution of generalized lichen nitidus after daily natural sunlight exposure. This case demonstrates a rare variant of lichen nitidus and a practical treatment alternative to in-office phototherapy.


Asunto(s)
Helioterapia , Liquen Nítido/terapia , Niño , Humanos , Masculino
11.
Int J Dermatol ; 58(4): 472-476, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30506679

RESUMEN

BACKGROUND: Noncultured epidermal cell suspension (NCES) is an effective surgical modality for stable vitiligo which involves transplantation of the basal layer of epidermal cells onto the dermabraded vitiliginous patch. Platelet-rich plasma (PRP) has growth factors which may stimulate melanocyte migration and proliferation of keratinocytes and fibroblasts. The objective of this study was to compare the extent of repigmentation achieved by transplantation of NCES suspended in PRP with that of NCES suspended in phosphate buffered saline (PBS). METHODS: Twenty-one patients of stable vitiligo with at least two lesions of comparable size were included. The two vitiligo patches were randomized to receive NCES suspended in PRP or PBS. Postoperatively after 1 week, patients were given heliotherapy for 15 minutes daily. RESULTS: At 6 months follow-up, mean repigmentation by area method in PRP arm was 75.6 ± 30% SD and in non-PRP arm was 65 ± 34% SD (P = 0.0036). Patient satisfaction by visual analogue scale at 6 months also showed better results in PRP arm (P = 0.001). Assessment by three independent observers showed better repigmentation in PRP side both at 3 and 6 months. CONCLUSIONS: Suspending NCES in PRP can result in significantly greater mean repigmentation and patient satisfaction than suspending in PBS.


Asunto(s)
Células Epidérmicas/trasplante , Plasma Rico en Plaquetas , Pigmentación de la Piel , Vitíligo/terapia , Adolescente , Adulto , Método Doble Ciego , Femenino , Helioterapia , Humanos , Masculino , Satisfacción del Paciente , Solución Salina , Trasplante Autólogo/métodos , Resultado del Tratamiento , Adulto Joven
13.
Acta Derm Venereol ; 98(2): 256-261, 2018 Feb 07.
Artículo en Inglés | MEDLINE | ID: mdl-28815268

RESUMEN

Dead Sea climatotherapy (DSC) is a therapeutic modality for a variety of chronic skin conditions, yet there has been scarce research on the relationship between the cutaneous microbiota and disease states in response to DSC. We characterized the skin bacterial and fungal microbiome of healthy volunteers who underwent DSC. Bacterial community diversity remained similar before and after treatment, while fungal diversity was significantly reduced as a result of the treatment. Individuals showed greater inter-individual than temporal bacterial community variance, yet the opposite was true for fungal community composition. We further identified Malassezia as the genus driving temporal mycobiome variations. The results indicate that the microbiome remains stable throughout DSC, while the mycobiome undergoes dramatic community changes. The results of this study will serve as an important baseline for future investigations of microbiome and mycobiome temporal phenomena in diseased states.


Asunto(s)
Bacterias/crecimiento & desarrollo , Balneología/métodos , Climatoterapia/métodos , Hongos/crecimiento & desarrollo , Helioterapia/métodos , Microbiota , Piel/microbiología , Bacterias/clasificación , Femenino , Hongos/clasificación , Voluntarios Sanos , Humanos , Israel , Malassezia/crecimiento & desarrollo , Masculino , Micobioma , Factores de Tiempo
14.
Licere (Online) ; 20(4): 107-128, dez.2017.
Artículo en Portugués | LILACS | ID: biblio-880116

RESUMEN

Neste ensaio refletimos sobre o corpo e sua aparência, considerando-se o contato com o sol, as práticas de proteção solar e as técnicas de bronzeamento. De um lado, os investimentos em torno da proteção contra os raios ultravioletas, não apenas com a proteção de cremes solares, mas de roupas que prometem proteção de 98% da superfície coberta. De outro lado, o bronzeamento natural feito na praia ou em clínicas especializadas. Essas técnicas e práticas aportam elementos para nossa reflexão sobre a ecologia corporal ao nos permitir pensar a respeito da relação entre o corpo íntimo e social, as aparências, o desejo, as significações sociais construídas pela medicina, cosmetologia e pelo lazer.


In this paper we reflect on the body and its appearance, considering the contact with the sun and the tanning and protection practices. On the one hand, investments around protection against ultraviolet rays, not only with the protection of solar creams, but with clothes that promise protection of 98% of the surface covered. On the other hand, the natural tanning done in specialized clinics. These practices provide elements for our reflection on body ecology by allowing us to think about the relationship between the intimate and social body, appearances, desire, social meanings built by medicine, cosmetology and leisure.


Asunto(s)
Neoplasias Cutáneas , Protectores Solares , Salud , Factores de Riesgo , Cámaras de Bronceado , Baño de Sol , Fluidoterapia , Helioterapia
15.
Early Hum Dev ; 114: 11-15, 2017 11.
Artículo en Inglés | MEDLINE | ID: mdl-28919246

RESUMEN

Challenges in treating severe neonatal jaundice in low and middle-income country settings still exist at many levels. These include: a lack of awareness of causes and prevention by families, communities and even sometimes health care professionals; insufficient, ineffective, high quality affordable diagnostic and therapeutic options; limited availability of rehabilitation provision for kernicterus. Collectively these challenges lead to an unacceptably high global morbidity and mortality from severe neonatal jaundice. In the past decade, there has been an explosion of innovations addressing some of these issues and these are increasingly available for scale up. Scientists, healthcare providers, and communities are joining hands to explore educational tools, low cost screening and diagnostic options including at point-of-care and treatment modalities including filtered sunlight and solar powered phototherapy. For the first time, the possibility of eliminating the tragedy of preventable morbidity and mortality from severe NNJ is on the horizon, for all.


Asunto(s)
Helioterapia/métodos , Ictericia Neonatal/prevención & control , Fototerapia/métodos , Países en Desarrollo , Femenino , Helioterapia/economía , Humanos , Recién Nacido , Ictericia Neonatal/diagnóstico , Ictericia Neonatal/epidemiología , Ictericia Neonatal/terapia , Fototerapia/economía
16.
Acta Derm Venereol ; 97(8): 934-940, 2017 Aug 31.
Artículo en Inglés | MEDLINE | ID: mdl-28536730

RESUMEN

Alexithymia, defined as difficulty in describing or recognizing emotions, has been shown to be connected with psoriasis, but its relationship with self-management of psoriasis has not been explored. The aim of this study was to assess the frequency of alexithymia and its relationship with self-management and illness perception in the context of psoriasis. A total of 163 patients participating in 3 weeks of climate heliotherapy (CHT) at Gran Canaria were assessed for alexithymia using the Toronto Alexithymia Scale (TAS-20) at baseline. Self-reported measures for self-management (Health Education Impact Questionnaire; heiQ), and disease severity and illness perception (Brief Illness Perception Questionnaire; BIPQ) were assessed twice. Of all patients, 14.1% were characterized as alexithymic and 22.1% scored in the intermediate range. Alexithymic patients scored significantly worse in all heiQ domains, and reported worse illness perception. However, there were no between-group differences in heiQ or BIPQ change from baseline to after CHT. In conclusion, this study shows that alexithymia indicates inferior self-management and reaffirms the associations with illness perception. Further research is required into these relationships.


Asunto(s)
Síntomas Afectivos/psicología , Síntomas Afectivos/terapia , Helioterapia , Entrevista Motivacional , Psoriasis/psicología , Psoriasis/terapia , Autocuidado/métodos , Autoimagen , Adulto , Síntomas Afectivos/diagnóstico , Anciano , Costo de Enfermedad , Femenino , Conocimientos, Actitudes y Práctica en Salud , Humanos , Masculino , Persona de Mediana Edad , Medición de Resultados Informados por el Paciente , Psoriasis/diagnóstico , Calidad de Vida , Autoinforme , Índice de Severidad de la Enfermedad , Suecia , Factores de Tiempo , Resultado del Tratamiento , Adulto Joven
18.
Photochem Photobiol Sci ; 16(3): 416-425, 2017 Mar 16.
Artículo en Inglés | MEDLINE | ID: mdl-28102417

RESUMEN

The Ultraviolet (UV) radiation contained in sunlight is a powerful mutagen and immune suppressant which partly explains why exposure to solar UV is the biggest risk factor for the development of cutaneous tumours. Evidence is building that sunlight may be protective against some internal malignancies. Because patients with these tumours are often vitamin D deficient, this has led some to propose that vitamin D supplementation will be beneficial in the treatment of these cancers. However, the results from already completed trials have been disappointing which has given weight to the argument that there must be something else about sunlight that explains its cancer-protecting properties.


Asunto(s)
Helioterapia , Neoplasias Cutáneas/terapia , Luz Solar , Deficiencia de Vitamina D/tratamiento farmacológico , Vitamina D/uso terapéutico , Suplementos Dietéticos , Humanos , Neoplasias Cutáneas/complicaciones , Insuficiencia del Tratamiento , Vitamina D/administración & dosificación , Deficiencia de Vitamina D/complicaciones
20.
J R Coll Physicians Edinb ; 47(3): 276-280, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29465107

RESUMEN

Since the 18th century tuberculosis has been a major cause of death throughout the world. It is a highly infectious disease that spreads by droplet infection and finding effective treatment to combat tuberculosis took a great deal of time. One of the first treatments to have some real success was a stay in a sanatorium. Sanatoria were homes that provided patients with good food and fresh air (and therefore sunlight). The first sanatorium to use sunlight therapy (heliotherapy) seriously was founded in Leysin, Switzerland, by Auguste Rollier. Patients built up their sun exposure gradually to prevent sunburn or skin damage. We suggest that heliotherapy was more successful in treating tuberculosis than was appreciated once chemotherapy became available. The birth of heliotherapy coincided with an increased appreciation of the association of sunlight and health among the general public. The secret of its success is the combined effects of sunlight on the skin inducing the production of nitric oxide and vitamin. Nitric oxide is not only a messenger in the cardiovascular system and responsible for relaxation of vascular muscle but is also involved in the innate immune system. Vitamin D is responsible for immune system functions and multiple studies have found an association between tuberculosis immunity and high vitamin D levels. Therefore, it is understandable that providing tuberculosis patients with sunlight may have boosted their immune system and aided them in the fight against tuberculosis. In view of the high level of resistance to all drug regimens in some patients, perhaps it is time to revive the use of sanatoria in the fight against tuberculosis.


Asunto(s)
Helioterapia , Hospitales , Luz Solar , Tuberculosis/terapia , Helioterapia/historia , Historia del Siglo XIX , Historia del Siglo XX , Historia Medieval , Hospitales/historia , Humanos , Óxido Nítrico/metabolismo , Piel/metabolismo , Tuberculosis/historia , Tuberculosis/metabolismo , Vitamina D/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...